SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,381 | -10.9% | 16,712 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $433,731 | +37.1% | 16,542 | +34.6% | 0.00% | 0.0% |
| Q1 2023 | $316,396 | -1.0% | 12,292 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $319,715 | -38.0% | 12,292 | -32.1% | 0.00% | 0.0% |
| Q3 2022 | $516,000 | +16.0% | 18,092 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $445,000 | -22.1% | 18,092 | +78.7% | 0.00% | 0.0% |
| Q1 2022 | $571,000 | -8.9% | 10,122 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $627,000 | -2.3% | 10,122 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $642,000 | -20.7% | 10,123 | +3.1% | 0.00% | -50.0% |
| Q2 2021 | $810,000 | +29.2% | 9,823 | +15.3% | 0.00% | +100.0% |
| Q1 2021 | $627,000 | +3.0% | 8,518 | +1.4% | 0.00% | 0.0% |
| Q4 2020 | $609,000 | +76.0% | 8,398 | +15.7% | 0.00% | 0.0% |
| Q3 2020 | $346,000 | +29.6% | 7,258 | +14.2% | 0.00% | 0.0% |
| Q2 2020 | $267,000 | – | 6,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |